IDEXX Laboratories (FRA:IX1) YoY EBITDA Growth : 8.45% (As of Sep. 2024)

View and export this data going back to 1991. Start your Free Trial

What is IDEXX Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IDEXX Laboratories's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 8.45%.

IDEXX Laboratories's EBITDA per Share for the three months ended in Sep. 2024 was €3.70.

IDEXX Laboratories YoY EBITDA Growth Historical Data

The historical data trend for IDEXX Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories YoY EBITDA Growth Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

15.26

13.74

41.38

6.48

17.78

IDEXX Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															3.68	5.80	6.19	-6.43	8.45

IDEXX Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IDEXX Laboratories's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(13.296	-	11.289)	/	\| 11.289 \|
=	17.78 %

IDEXX Laboratories's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(3.696	-	3.408)	/	\| 3.408 \|
=	8.45 %

IDEXX Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (FRA:IX1) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico 0J8P:UK IX1:Germany I1DX34:Brazil IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

IDEXX Laboratories Headlines

No Headlines